Treatment of relapsed CD20+ Hodgkin lymphoma with the monoclonal antibody rituximab is effective and well tolerated: results of a phase 2 trial of the German Hodgkin Lymphoma Study Group
Titel:
Treatment of relapsed CD20+ Hodgkin lymphoma with the monoclonal antibody rituximab is effective and well tolerated: results of a phase 2 trial of the German Hodgkin Lymphoma Study Group
Auteur:
Rehwald, Ute Schulz, Holger Reiser, Marcel Sieber, Markus Staak, Jan Oliver Morschhauser, Franck Driessen, Christoph Rüdiger, Thomas Müller-Hermelink, Konrad Diehl, Volker Engert, Andreas